
ã¢ã¡ãªã«ã®HPVã¯ã¯ãã³è£å€è³æããã³ããŒã¯ã®å»åž«ããã®èŠåãç¡èŠ
SNSã§ã¯ãHPVã¯ã¯ãã³ã®è¬å®³ã§éšãã§ããã®ã¯æ¥æ¬ã ãã ããšãã人ãããŸãããä»åœã§ã蚎èšã¯èµ·ããŠããŸããã¢ã¡ãªã«ã§ã¯6æã«å€§ããªåãããããçŽ200ä»¶ãã£ãHPVã¯ã¯ãã³ã«é¢ãã蚎èšããŸãšããŠã補è¬äŒç€ŸïŒã¡ã«ã¯ç€ŸïŒãçŽ5000äžãã«ïŒçŽ80ååïŒãæ¯æã£ãŠåè§£ããããšã«ãªã£ãããã§ãããã®äžã®1人ãJennifer Robiããã®èšŽèšã¯å€§ããªæå³ããã£ãã®ã§ããããã®èšŽèšãåè§£ãšãªããŸãããRobiããã®è£å€è³æããã¯æ§ã ãªããšãæããã«ãªã£ãŠããã®ã§ãå°ããã€æãèµ·ããããšæããŸãããã®èšäºã¯ã2æ¬ç®ã§ãã
ãã³ããŒã¯ã®å»åž« Jesper Mehlsenæ°
ååã®ç¶ãã§ãã
Robiãããéãã®äžã§åŸãæ å ±ã¯ãè£å€è³æãšããŠäžèšã§ãå ¬éãããŠããŸãã
ãããã®è³æã¯èšŽèšã«åã€ããã«èšŒæ ãšããŠæåºããããã®ã§ãããé°è¬è«ã§ãããã§ããããŸããã
ä»åããã¢ã¡ãªã«ã§ã®èšŽèšã«ã€ããŠè©³ããå ±ããŠããæ°å°ãªãã¡ãã£ã¢ã®ïŒã€ããChildrenâs Health DefenseãïŒã¹ãã³ãµãŒã«é Œããªãç¬ç«ç³»ã®ã¡ãã£ã¢ïŒã®èšäºãå
ã«è£å€è³æã確èªããŸããã
å°éçãªå 容ãªã®ã§ç¿»èš³ãµã€ãã䜿ããŸãããèš³ãééããªã©ããããããããŸãããããèŠã€ããŸããããã³ã¡ã³ãã§ãææãã ããã
HPVã¯ã¯ãã³ãã¬ãŒãã·ã«ãã®è£œé å ã§ããã¡ã«ã¯ç€Ÿã¯ãå米以å€ã§ã¯MSD (Merck Sharp and Dohme) ãšãã瀟åã§ããžãã¹ãè¡ã£ãŠããã®ã§ãæ¥æ¬ã§ã¯MSDã§ãã
Merck Ignored Gardasil Safety Warnings From Its Own Trial Investigator, Court Documents Reveal
èšäºã®ãªãŒãã«ã¯ããã³ããŒã¯ã®å»åž«Jesper Mehlsenæ°ãäžéšã®æ¥çš®è ã«èŠãããPOTSïŒäœäœæ§é »èçå矀ïŒãæ ¢æ§ç²åŽã«äŒŒãçç¶ã«ã€ããŠããã®åå ã¯HPVã¯ã¯ãã³ïŒã¬ãŒãã·ã«ïŒã§ããå¯èœæ§ãé«ããšçµè«ä»ãããšããããšãšãã¡ã«ã¯ç€Ÿã«å¯Ÿãã蚎èšã§èšŒæ ãšããŠæåºãããå ±åæžã®äžã§ãMehlsenæ°ã¯å瀟ãå®å šæ§ã«é¢ããèŠåãç¡èŠããŠãããšææããŠããããšãæžãããŠããŸãã
èšäºã«ãæžãããŠããŸãããMehlsenæ°ã¯ã¡ã«ã¯ç€Ÿã®ã¬ãŒãã·ã«èšåºè©Šéšãäž»å°ããŠããå»åž«ã§ãã
è£å€è³æã«ããã®ããšãæžãããŠããŸãã
Expert Report - Probable side effects to vaccination with Gardasil; in Robi v Merckããã

HPVãšåå®®é žãããšã®é¢é£ã瀺ãç ç©¶ãããŠããçµæŽããããã¡ã«ã¯ç€Ÿã«ãã4䟡ããã³9䟡ã®ã¬ãŒãã·ã«ã¯ã¯ãã³ã«é¢ããç ç©¶ã«ãããŠäž»ä»»ç ç©¶è ãåãããšæžãããŠããŸããããã«ã35幎以äžã«ããã£ãŠèªåŸç¥çµé害ã«é¢ããç ç©¶ãè¡ã£ãŠããŸããã
ãã®ãããªäººç©ããã®èŠåã§ãã£ãããšããéåžžã«éèŠã ãšæããŸããMehlsenæ°ã¯ããããããåã¯ã¯ãã§ã¯ãªãç«å Žã®å»åž«ãªã®ã§ãã
èšäºã«ã¯ãMehlsenæ°ã¯2014幎12ææç¹ã§ãã¬ãŒãã·ã«ã«é¢é£ããèªå·±å ç«æ§ã®æå®³äºè±¡ãç¹å®ããã¡ã«ã¯ç€Ÿã«èŠåã詊ã¿ãããå瀟ã®ç±³åœäºåæã¯åœŒã®æžå¿µãç¡èŠããç ç©¶è ããæåºãããæå®³äºè±¡å ±åæžã®åãå ¥ããæåŠãããšæžãããŠããŸãã
Mehlsenæ°ãæåºããå ±åæžã«ãããšã2011幎ãHPVã¯ã¯ãã³æ¥çš®çŽåŸããèµ·ç«äžèçãäž»ãšããçç¶ã蚎ããæ£è ãåããŠç¢ºèªããã åæ§ã®ç æŽãæã€æ£è æ°ãå¢å ããã®ã§ãã¢ã³ã±ãŒã調æ»ãæšæºçãªè¡æ¶²æ€æ»ãèªå·±å ç«ã«é¢ããæ€æ»ãããã³ã³ããªã¢æ©èœã®è§£æãå ç«ç³»ã®è§£æãããã³å¿è¡ç®¡ç³»ã®èªåŸç¥çµèª¿ç¯æ©èœã®æž¬å®ãéããŠãäœç³»çã«ããŒã¿ãåéãå§ããããã§ãããã®ç ç©¶ã¯ããã³ããŒã¯æ¿åºããã®å©æéã«ãã£ãŠè³éæäŸãåããæåã®53åã®æ£è ã«é¢ããè«æã2015幎ã«çºè¡šããŸããã
è«æã§ã¯ã ãå ±åãããçç¶ã«ã¯äžè²«æ§ãèŠããããŸãæã ã®æèŠãšä»è ã«ããå ±åãšã®éã«ãæŽåæ§ãèªããããŸãããæã ã®æèŠã¯ãHPVã¯ã¯ãã³ãšã®å æé¢ä¿ã確å®ãããã®ã§ãåŠå®ãããã®ã§ããããŸãããããããã®æ£è ã«èŠãããçç¶ã®èåŸã«ããç æ ççãè§£æããå æé¢ä¿ã®å¯èœæ§ãšãã®æ§è³ªãè©äŸ¡ããããã«ã¯æšçãçµã£ãæ²»çæ³ã確ç«ããããã«ããããªãç ç©¶ãç·æ¥ã«å¿ èŠã§ããããšã瀺åããŠããŸãããšçµè«ã¥ããŠããŸãã
ãã®åŸãå¯Ÿç §çŸ€ãå«ã839åã®ç޹仿£è ã察象ãšãã远跡調æ»ã«é¢ããè«æãã2022幎ã«ãJournal of Autoimmunityãã«æ²èŒã
https://www.sciencedirect.com/science/article/abs/pii/S0896841122001299
åæã®çµæãHPVã¯ã¯ãã³æ¥çš®ã«ããå¯åå¿ãçãããå°å¥³ãè¥å¹Žå¥³æ§ã¯ãME/CFSïŒççæ§è³èé«çïŒæ
¢æ§ç²åŽçå矀ïŒããã³ã°COVIDïŒæ°åã³ãããŠã€ã«ã¹ææçã®é·æåŸéºçïŒã®äžéšã«èŠããããã®ãšé
·äŒŒããèªå·±å
ç«çŸæ£ã«åèŽããçç¶ãçç©åŠçããŒã«ãŒãæããŠããããšãæããã«ãªã£ããšããŠããŸããããã«ãäœããã®åºç€çŸæ£ãçŽ å ããäžéšã®å人ã«ãããŠã¯ã¯ãã³é¢é£ã®æå®³äºè±¡ã«å¯Ÿããè匱æ§ãçããããŠããå¯èœæ§ã瀺åãããã®ã§ãå人ã®è匱æ§ã®å¯èœæ§ã«ã€ããŠãããªã調æ»ãšæ€èšãè¡ãã¹ãã§ãããšã®ããšã§ãã
ã¡ã«ã¯ç€ŸãšEMAïŒæ¬§å·å»è¬ååºïŒã®å¯Ÿå¿
Mehlsenæ°ã¯2014幎12æ2æ¥ãåœæã¡ã«ã¯ç€Ÿã®ã°ããŒãã«èšåºè©Šéšæ¥åæ åœå¯ç€Ÿé·ã§ãã£ãå»åž«ã«å¯Ÿããã¡ãŒã«ã§æ³šæåèµ·ããããšè©Šã¿ããšãããã¡ã«ã¯ã»ãã³ããŒã¯æ³äººã¯ããã«çè§£ã瀺ãããã®ã®ãã¡ã«ã¯ç±³åœæ¬ç€ŸãMehlsenæ°ã®æžå¿µãéãããšæžãããŠããŸãã

ãããŠEMAïŒæ¬§å·å»è¬ååºïŒã¯2015幎ãã¬ãŒãã·ã«ãšæå®³äºè±¡ãšã®é¢é£ã瀺åããå ±åãç¡èŠããŠã補é å ããã®ããŒã¿ãå°éå®¶ã®èŠè§£ã«åºã¥ããHPVã¯ã¯ãã³æ¥çš®ãšé節ãªèªå·±å ç«çŸæ£ãç¥çµç³»æå®³äºè±¡ãšã®éã«é¢é£æ§ã¯ãªããšå®£èšãããšæžãããŠããŸãã

Mehlsenæ°ã¯ããã©ã»ãåé¡ïŒäžèšåç
§ïŒã«ã€ããŠãèšåããŠããŸãã
ãã©ã»ããççé£å¡©æ°Žã§ã¯ãªãã¢ãžã¥ãã³ããå«ãŸããŠããããšã«ã€ããŠãEMAã®å°éå®¶ã°ã«ãŒãïŒå€éšïŒã®å»åž«2åã«ãã£ãŠããªãŒãã£ã³ã°ã»ããŒãã§ææãããŠããã®ã«ãEMAã®å ¬åŒå ±åæžã«ã¯èšèŒãããªãã£ãããã§ãã
ã¢ã¡ãªã«ã®è£å€è³æãèªããšãååŽçãšåæ§ã«ãFDAãEMAãåœæ°ã®å®å šãã補è¬äŒç€Ÿã®å©çãå®ãããšããŠãããããªèšåã§ãããã®ãããªããšãè¡ãããŠããã®ã«ãååŽçãFDAãEMAããããå®å šããä¿¡ããããã§ããããã
Mehlsenæ°ã®å ±åæžã«ã¯ãä»ã®è«æããã®èå¯ãèšãããŠããŸãããã®äžã§ãæ¥æ¬ã®åå€å±åžèª¿æ»ã«ã€ããŠã¯ãããããåå€å±ã¹ã¿ãã£ãšåŒã°ããŠããéŽæšè«æã§ã¯ãªããåãããŒã¿ãåè§£æããå «éã»æ€¿è«æïŒäžèšïŒãåãäžããŠããŸãã
ãåå€å±èª¿æ»ã®ããŒã¿ãçšãããã®è§£æã«åºã¥ããšãHPVã¯ã¯ãã³æ¥çš®ãšãèªç¥æ©èœé害ãéåé害ãšãã£ãç¹å®ã®çç¶ãšã®éã«ãé¢é£æ§ãååšããå¯èœæ§ããããHPVã¯ã¯ãã³æ¥çš®ãšãããã®çç¶ãšã®éã®æç¢ºãªå æé¢ä¿ã«ã€ããŠã¯ãäŸç¶ãšããŠäžç¢ºå®ã§ããããçç¶ã®é節ããèæ ®ãããšãHPVã¯ã¯ãã³ã®å®å šæ§ã確èªããããã«ã¯ãããå æ¬çãã€å€§èŠæš¡ãªç ç©¶ãäžå¯æ¬ ã§ãããšèè ãã¯èããŠããããšèšããŠããŸãã
åå€å±åžã®èª¿æ»ãšã¯ãéµéã¢ã³ã±ãŒãã§ãããã®ãããªéµéã¢ã³ã±ãŒãã§ãæ¥çš®ãšçç¶ãšã®ãå æé¢ä¿ããªãããšèšããã¯ãããããŸããïŒäžèšåç §ïŒãã ããããããããªã調æ»ãå¿ èŠã ã£ãã®ã«ã宿œãããŸããã§ããã
Mehlsenæ°ã¯ãå ±åæžãäžèšã®ããã«ç· ãããã£ãŠããŸãã
ç§ã®æè²ãçµéšãç ç©¶ã調æ»ãåæãæç®ã®æ€èšãããã³æ¬å ±åæžã§ç¹å®ãããè³æã«åºã¥ããå»åŠçã»ç§åŠçã«çžåœãªçšåºŠã®ç¢ºä¿¡ããã£ãŠä»¥äžã®éãèŠè§£ãè¿°ã¹ãŸããããªãã¡ãã¬ãŒãã·ã«ã¯ãPOTSïŒäœäœæ§é »èçå矀ïŒããªãã³ã«ççæ§è³èé«çïŒME/CFSïŒãæ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒçœ¹æ£åŸçå矀ã«é¡äŒŒããèªå·±å ç«çŸæ£ã®æåãªåå ã§ãããšèããããŸãããããã®çå矀ã«ãããŠã¯ãã¬ãŒãã·ã«ã«èµ·å ããèªåŸç¥çµç³»ã®æ©èœé害ãé¡èã§ãããé床ã®èµ·ç«äžèæ§ãããªãã¡POTSã®çç¶ãåããŠããŸãã
ããäžåºŠæžããŸãããMehlsenæ°ã¯HPVãšåå®®é žãããšã®é¢é£ã瀺ãç ç©¶ãããŠããçµæŽããããã¡ã«ã¯ç€Ÿã«ãã4䟡ããã³9䟡ã®ã¬ãŒãã·ã«ã¯ã¯ãã³ã«é¢ããç ç©¶ã«ãããŠäž»ä»»ç ç©¶è ãåããããã«ã35幎以äžã«ããã£ãŠèªåŸç¥çµé害ã«é¢ããç ç©¶ãè¡ã£ãŠããå»åž«ã§ããããã©ããéå»ã®çµéšã ãã§å€æããŠããã®ã§ã¯ãããŸããã
HPVã¯ã¯ãã³æ¥çš®åŸã®æ£è ã蚺å¯ããçµæããããŸã§ã®çµéšããã¯å€æã§ããªããããªããšãèµ·ããŠããŠãã¬ãŒãã·ã«ãæåãªåå ãšããŠèãããããããé¢é£ã調ã¹ãã¹ãã ãšèšã£ãŠããã®ã§ãã
ããã«å¯ŸããŠã被ååŽãåè«ã®è³æãåºããŠããŸãã

é·ã ãšåè«ãæžãããŠããã®ã§å šéšã«ç®ãéããããã§ã¯ãããŸããããçµè«ã«Mehlsenæ°ã¯ãå§åçãªæš©åšããç¥èŠãç¡èŠããŠããããšæžãããŠããŸãã
ãå§åçãªæš©åšããç¥èŠãã¯ãå®å šæ§ãžã®æžå¿µã«ã€ãªããæ°ããªå¯èœæ§ãçºèŠãããŠããããããªããã®ãªã®ã§ããããã
æ§ã ãªå ±åãåºãŠããã«ãé¢ããããã¡ã«ã¯ç€Ÿã¯èªåãã¡ã§è¢«å®³è ã®äœå ã§äœãèµ·ããŠããã調ã¹ãããšããã«ããæš©åšããç¥èŠãã«é Œã£ãŠMehlsenæ°ãžã®åè«ãæåºããŠããŸãã
Mehlsenæ°ã¯åœåããããããªãç ç©¶ãç·æ¥ã«å¿ èŠã§ãããšèšã£ãŠããŸãããã¡ã«ã¯ç€Ÿã«ããã¬ãŒãã·ã«ã¯ã¯ãã³ã®ç ç©¶ã«ãããŠäž»ä»»ç ç©¶è ãåããå»åž«ã®èŠåãããªãã¡ã«ã¯ç€Ÿã¯ç¡èŠãç¶ããŠããã®ã§ããããã
ãã®ãŸãŸã§ã¯ãä»åŸãç¡èŠãç¶ããã§ãããããã¡ããšç ç©¶ã調æ»ãé²ããæ¬åœã®æå³ã§å®å šã確èªããããã«ã¯ãæ¥æ¬ã®è£å€ã§å蚎ããªããã°ãªããŸãããå蚎ããããã«ã¯ãäžè«ã®åŸæŒããå¿ èŠãªã®ã§ãã
è£å€ã®ç®çãªã©ã«ã€ããŠã¯ãäžèšã«ã詳ããæžãããŠããŸãã
è£å€æå®
ååŽçå®
å€äŒã¿äžã«ã¯ãå šåœåå°ã§ååãããã¡ã®ã声ããèããã€ãã³ããããããéå¬ãããŸãããªã³ã©ã€ã³åå ã§ãããã®ãããã®ã§ããã²ååãããã¡ã«èµ·ããŠãããäºå®ããç¥ãããšããŠãã ãããèªåã§ç¥ãããšããªããã°ãåœã補è¬äŒç€ŸãæµããŠããã被åã«ãšã£ãŠéœåã®ããæ å ±ãããå ¥ã£ãŠããªãã®ã§ãã
HPVã¯ã¯ãã³åé¡ã€ãã³ãã¹ã±ãžã¥ãŒã«








ïŒé¢é£èšäºïŒ
HPVã¯ã¯ãã³åé¡ãæ¢ç©¶å°èª¬ã«ããŠã¿ãŸããïŒ